MED COVID-19: Understanding barriers to health equity (Milestone 1.U)
In Progress
Timeline Start - End
2022 - 2027Research Implementation Area
Population Studies and Precision MedicineAD-Related Dementias Focus
Explore interaction of social, structural, and systemic inequalities, comorbidities and social and medical interventions with risk and neurocognitive sequelae of COVID-19.
Success Criteria
- At least two research studies to determine and propose solutions for systemic sociocultural, economic, and health care system factors that are barriers to equitable AD/ADRD outcomes following COVID-19, including when comorbidities increase dementia risk.
Summary of Key Accomplishments
This milestone has just been initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of November 2022.
Accomplishments/Implementation Activities
Funding Initiatives
Research Programs and Resources
- 2022 ADRD Summit: Multiple Etiology Dementias (MED) Special Topic: Impact of COVID-19 on AD/ADRD Risk and Outcomes Milestone 3, Priority 3
- Select projects funded in FY22